Dr. Matthew J Krasin, MD

Claim this profile

St.Jude Children's Research Hospital

Studies Rhabdomyosarcoma
Studies Soft Tissue Sarcoma
3 reported clinical trials
8 drugs studied

Area of expertise

1

Rhabdomyosarcoma

Matthew J Krasin, MD has run 2 trials for Rhabdomyosarcoma. Some of their research focus areas include:

Stage IV
Stage II
Stage I
2

Soft Tissue Sarcoma

Matthew J Krasin, MD has run 1 trial for Soft Tissue Sarcoma. Some of their research focus areas include:

Stage IV

Affiliated Hospitals

Image of trial facility.

St Jude Children's Research Hospital

Clinical Trials Matthew J Krasin, MD is currently running

Image of trial facility.

Proton Beam Radiation

for Wilms Tumor

Participants are being asked to take part in this clinical trial, a type of research study, because the participants have a Wilms Tumor cancer. Primary Objectives To determine whether delivery of proton beam radiation to a conformal reduced target volume in the flank allows normal flank growth compared to the contralateral untreated side and non-irradiated patients. Secondary Objectives To deliver proton beam radiation to a conformal reduced target volume (partial kidney proton beam radiation therapy) in the affected kidney(s) for patients with Stage V (bilateral Wilms tumor) and specific involved surgical margins yielding no reduction in the high control rates seen with more traditional flank / whole kidney fields. Exploratory Objectives * Study the feasibility of sparing the residual kidney, spine and liver in patients requiring whole abdomen radiation therapy using either a proton beam treatment technique or intensity-modulated radiation therapy ( IMRT) photon based technique. * Study the feasibility of delivering whole lung radiation therapy with proton beams with the goals of sparing the developing breast tissue, heart structures, thyroid and liver. * Develop simultaneous xenografts and organoid models from the same starting material to study Wilms tumor biology and compare responses to chemotherapeutic agents. * Define the evolution of organ specific (kidney, liver, pancreas, etc.) abnormalities (laboratory studies) as an early marker of possible late end organ damage and their relationship to radiation. * Study and evaluate impact of proton therapy on the musculoskeletal system and physical performance and compare with photon therapy cases treated with classical treatment fields. * Assess CTC-AE and Pediatric Patient Reported Outcomes during radiation and in follow-up, correlating with disease, treatment and patient variables. * Correlate quantitative MRI values, including apparent diffusion coefficient (ADC) values, with histopathology findings post-surgery in children with (bilateral) Wilms. * Assess daily variations in proton range along each treatment beam using standard pre-treatment cone beam CT or on-treatment MR.

Recruiting

1 award

Phase 2

10 criteria

More about Matthew J Krasin, MD

Clinical Trial Related

4 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 1 Active Clinical Trial

Treatments Matthew J Krasin, MD has experience with

  • Image-guided Radiotherapy
  • Bevacizumab
  • Cyclophosphamide
  • Dactinomycin
  • Proton Beam Radiation
  • Surgical Resection

Breakdown of trials Matthew J Krasin, MD has run

Musculoskeletal Tumors

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Matthew J Krasin, MD specialize in?

Is Matthew J Krasin, MD currently recruiting for clinical trials?

Are there any treatments that Matthew J Krasin, MD has studied deeply?

What is the best way to schedule an appointment with Matthew J Krasin, MD?

What is the office address of Matthew J Krasin, MD?

Is there any support for travel costs?